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Chapter 1. General introduction 
 
1-1. Introductory remarks 
Stroke is a major cause of death and long-term disability worldwide, and these problems 
are being addressed by a wide variety of research fields, including pharmacology, 
medicine, and neuroscience (Strong et al., 2007; Kim & Bae, 2017). Neuroscience 
research has provided important insights into the mechanisms underlying dysfunction 
associated with stroke and recovery by rehabilitation. 
Artificial damage to the primary motor cortex (MI), the area essential for movement 
of the extremities, resulted in motor paralysis in animal models, characterized by 
difficulty in gripping and walking (Armstrong, 1988; Murata et al., 2008; Murata et al., 
2015). However, the animals sometimes showed spontaneous recovery from motor 
paralysis. This was thought to be due to neural plasticity, with undamaged brain regions 
compensating for the lost function (Nudo et al., 1996; Dimyan & Cohen, 2011; Murata et 
al., 2015; Ishida et al., 2016). Investigation of neural plasticity using various methods, 
including molecular biology, histology, electrophysiology, will help to elucidate the 
mechanisms underlying behavioral and cognitive changes after brain damage, and will 
also contribute to the development of novel clinical interventions such as drugs. 
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Neural plasticity, mentioned above, is an example of beneficial plastic changes that 
improve functional recovery. However, neural plasticity may also have negative effects 
on brain function (Vance et al., 2009; Dietz, 2012). A research topic of current interest 
regarding negative effects of plasticity is neuropathic pain, which develops after nerve 
injury (Woolf & Salter, 2000; Bliss et al., 2016). Central post-stroke pain (CPSP), which 
is addressed here, has also been suggested to be caused by central nervous system 
plasticity (Apkarian, 2011). Animal models using rodents have been developed and 
characterized to reveal the plasticity underlying CPSP (Wasserman & Koeberle, 2009; 
Hanada et al., 2014). However, some brain structures and functions differ between 
rodents and primates (Kaas, 2004; Wallis, 2012). Therefore, CPSP models using animals 
with brain structures and functions closer to those of humans are important for elucidating 
the underlying mechanisms. Here, a new animal model of CPSP was established using 
rhesus macaques (Experiment 1), which are closer to humans in both the brain structure 
and function. Histological analyses were then performed to confirm glial activation, 
which is considered to be involved in the abnormal pain (Experiment 2).  
 
1-2. Characteristics of CPSP  
First, the clinical findings of CPSP are introduced in this section. The findings of clinical 
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studies provide important insight into the underlying pathophysiological mechanisms. 
 
1-2-1. Epidemiology 
In addition to major symptoms such as early onset of hemiparesis, speech disabilities, and 
sensory deficits, late-onset pain also appears frequently as a result of cerebral vascular 
accidents (Leijon et al., 1989; Bowsher, 1995; Kumar et al., 2009). CPSP, a type of 
neuropathic pain, is a chronic pain syndrome associated with sensory abnormalities due 
to lesions in the somatosensory pathways of the central nervous system (Montes et al., 
2005; Kumar et al., 2009; Krause et al., 2012; Sprenger et al., 2012). CPSP was reported 
to occur after lateral medullary infarction (Wallenberg syndrome), pontine stroke, lateral 
midbrain stroke, posterolateral thalamus stroke, secondary somatosensory cortex stroke, 
and insular cortex stroke (Hosomi et al., 2015). CPSP is observed among in up to 10% of 
stroke patients (Hosomi et al., 2015), and the prevalence rate is high among patients with 
lateral medullary stroke (25%) or thalamus lesions (25%) (Andersen et al., 1995; 
MacGowan et al., 1997). Age, sex, stroke type (infarct or hemorrhage), and lesional 
hemisphere are not consistent predictors of CPSP (Klit et al., 2009). 
 
1-2-2. Pain characteristics 
6 
 
Typically, CPSP can emerge at any time from several weeks to several years after stroke 
(Kumar et al., 2009; Hosomi et al., 2015). Patients with CPSP complain about not only 
spontaneous pain but also evoked pain in which normally innocuous stimuli are perceived 
as painful, i.e., allodynia, or normally painful stimuli are perceived as even more painful, 
i.e., hyperalgesia. More than 90% of patients with CPSP show abnormalities in either 
thermal (cold or hot) or pain sensation (Leijon et al., 1989; Andersen et al., 1995). The 
abnormal pain is felt in the body region that is affected by sensory abnormalities, which 
corresponds topographically to the brain regions affected by the stroke lesion 
(Vestergaard et al., 1995). Thus, the pain symptoms commonly occur in the range from 
half of the body to restricted body areas contralateral to the lesion (Klit et al., 2009; Klit 
et al., 2011; Hosomi et al., 2015). In rare cases, some patients with CPSP have pain 
symptoms in areas of the body ipsilateral to the lesion (Kim, 1998). CPSP often reduces 
patients’ quality of life and frequently interferes with rehabilitation (Kumar et al., 2009). 
 
1-3. Physiological pain pathways and CPSP 
The mechanisms that produce allodynia or hyperalgesia resulting from brain lesions are 
poorly understood, as the basic mechanisms of physiological pain have not been fully 
elucidated. “Pain processing systems” are constructed by multiple ascending pathways 
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and a wide range of brain areas that are involved in two major aspects of pain, i.e., 
perception and emotion. First, the anatomical pathways associated with pain, the pain 
matrix, are discussed (Chapter1, 1-3-1 and 1-3-2). Then, evidence is presented indicating 
that the same pathways are involved in the occurrence of CPSP. 
 
1-3-1. Pathways from the spinal cord to the thalamus 
Peripheral sensory neurons, which have thinly myelinated fibers (Aδ) and unmyelinated 
C fibers, are activated by noxious stimuli. Aδ fibers transmit intense mechanical sensation, 
and C fibers transmit noxious mechanical, thermal, and chemical sensation. Both of these 
fiber types terminate in laminae I, II, and deeper lamina V of the spinal dorsal horn. 
Anatomical tracer studies in non-human primates and rodents indicated that nociceptive 
information is conveyed across the midline within the spinal cord and is mainly 
transmitted to the ventral posterolateral nucleus (VPL), ventral posteromedial nucleus 
(VPM), ventral medial posterior nucleus (VMpo), and mediodorsal nucleus (MD) of the 
thalamus through the lateral spinothalamic tract (Apkarian & Hodge, 1989; Apkarian & 
Shi, 1994; Almeida et al., 2004; Craig, 2004; 2008; Dum et al., 2009). The fibers also 
send branches to the lateral medulla, pons, or midbrain (Almeida et al., 2004) (Fig. 1).  
Sensory neurons with myelinated Aβ fibers principally transmit proprioceptive 
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and cutaneous information, i.e., somatic sensation, from a dermatome. Generally, the Aβ 
fibers mainly terminate in the lamina V neurons, which then project to the ipsilateral 
brainstem through spinal dorsal columns. The information is then conveyed to the 
contralateral side of the medulla toward the thalamus, where the projections mainly 
terminate in the VPL and VPM (Francis et al., 2008; McGlone & Reilly, 2010). 
 
1-3-2. Pain-associated pathways from the thalamus to the cerebral cortex 
The thalamus acts as a center of communication between many subcortical brain regions 
and the neocortices, and is divided into multiple subdivisions based on differences in 
architecture and both afferent and efferent connectivity. Here, the thalamic regions 
involved in pain are described. 
The neurons in the VPL with noxious responses mainly project to the primary and 
secondary somatosensory cortices, whose pathways are called the lateral pain system, and 
are involved in processing sensory features, such as the duration and location of pain 
(Kniffki & Mizumura, 1983; Kenshalo et al., 1988; Andersson et al., 1997; Greenspan et 
al., 1999; Ploner et al., 1999). On the other hand, the medial pain system, i.e., the pathway 
from the VMpo and MD to limbic structures, includes the cingulate and insular cortices 
(Saper, 1982; Hatanaka et al., 2003; Brooks & Tracey, 2005; Dum et al., 2009). As 
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patients with lesions in these regions show altered emotional responses to pain (Foltz & 
White, 1962; Berthier et al., 1988), the pathways are thought to mediate affective and 
motivational aspects of pain (Bushnell et al., 2013). 
 
1-3-3. Lesion sites and development of CPSP 
From an anatomical perspective, CPSP is typically associated with stroke lesions at 
multiple sites in the lateral spinothalamic tract and its terminations, which are involved 
in noxious transmission (pain and temperature) (Hosomi et al., 2015). Transmission of 
somatic sensory signals through the dorsal column pathway is typically spared in CPSP 
(Fig. 1). Importantly, it is still unclear whether the occurrence of CPSP is due to lesions 
of the MD or VMpo of the thalamus (Krause et al., 2012; Hosomi et al., 2015). 
Krause et al. mapped the lesion areas using T1-weighted anatomical brain imaging 
in 18 patients presenting with CPSP of thalamic origin, and found critical lesions in the 
VPL of the thalamus in these patients (Krause et al., 2012). The VPL, in which the 
spinothalamic tracts are known to terminate, is therefore a key area for the occurrence of 
CPSP. 
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1-4. Figure and figure legend 
 
 
Figure 1. Stroke sites associated with occurrence of CPSP. A simplified illustration of 
spinothalamic and thalamocortical pathways is summarized from the anatomical 
investigations on the pathways. Cortico-cortical pathways are not shown. The lateral 
spinothalamic tracts (red line) carry information from the spinal dorsal horn to the 
thalamus through the caudal medulla, rostral medulla, pons and midbrain. CPSP occurs 
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in case somewhere in this pathway is lesioned. On the other hand, the dorsal column 
pathways (blue) are typically spared in CPSP patients. The figure is modified from 
Hosomi et al., 2015 and Brooks and Tracey, 2005. 
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Chapter 2. [Experiment 1] Behavioral changes after a focal 
lesion of the VPL 
 
2-1. Introduction 
2-1-1. Rodent models of CPSP 
The CPSP is often caused by lesion of the lateral spinothalamic tract, however, its 
pathogenic mechanisms are not well understood. To address this problem, development 
of animal models for CPSP had been anticipated. In 2009, Wasserman and Koeberle first 
developed the CPSP animal model using rats based on hemorrhagic lesion in the VPL 
(Wasserman & Koeberle, 2009). Subsequently, many labs have investigated behavioral 
and histological changes in the rodent models following the induction of hemorrhage 
(Wasserman & Koeberle, 2009; Castel & Vachon, 2013; Hanada et al., 2014; Kuan et al., 
2015; Shih et al., 2017) or infarct (Takami et al., 2011; Tamiya et al., 2013; Blasi et al., 
2015) in the VPL. In clinical researches, pain perception is estimated by report from 
individual patients using the Visual Analogue Scale (subjective assessment of pain 
magnitude). However, in animal studies, the pain perception has to measure the 
behavioral response to presumed noxious stimulation (Percie du Sert & Rice, 2014). A lot 
of CPSP rodents model showed increased withdrawal responses to thermal and 
mechanical stimuli, which suggest the occurrence of characteristic symptoms of CPSP 
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patients (Wasserman & Koeberle, 2009; Takami et al., 2011; Castel & Vachon, 2013; 
Tamiya et al., 2013; Hanada et al., 2014; Blasi et al., 2015; Kuan et al., 2015; Shih et al., 
2017), and several studies assessed efficacy of a drugs on the behavioral change (Hanada 
et al., 2014; Kuan et al., 2015).   
 
2-1-2. Non-human primate model of CPSP 
In addition to these CPSP models using rodents, the model using the macaque monkey 
can also contribute both to understanding CPSP mechanisms and to developing novel 
therapeutic interventions for CPSP because the macaque monkey is more compatible with 
human in regard to functions and structures of brain regions which is suggested to be 
involved in allodynia and hyperalgesia by brain imaging study of human patients as 
described below (Willoch et al., 2004; Ducreux et al., 2006; Casey et al., 2012). Previous 
meta-analysis of fMRI and positron emission tomography (PET) experiments in patients 
with abnormal pain after peripheral nerve damage and brainstem stroke suggest that brain 
activity of the lateral and medial pain pathways were significantly increased, compared 
with normal pain in healthy human subjects (Lanz et al., 2011). Moreover, a recent MRI 
study using voxel-based morphometry (VBM) indicates that the patients with CPSP are 
accompanied by a maladaptive atrophy in several cortical areas including the sensory and 
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prefrontal cortices, where sensory and emotional aspects of pain are processed (Krause et 
al., 2016). These evidence strongly suggest that functional or structural plasticity occurs 
in a wide-range of brain regions, and therefore it is important to elucidate plasticity that 
underlies CPSP. However, some of the brain structures and functions are known to be 
different between rodents and primates (Kaas, 2004; Wallis, 2012).  
 
2-1-3. Complex sensory systems of non-human primates 
In the rhesus macaque, the primary somatosensory cortices, which are associated with 
sensory aspects of pain (Bushnell et al., 1999), are clearly differentiated into four 
subdivisions, i.e., Brodmann’s areas 3a, 3b, 1 and 2 (Kaas, 2004). Areas 3b and 1 are 
known to receive projections from neurons in the contralateral spinal laminae I and V via 
the spinothalamic tract and VPL. Area 3b forms a systematic representation of the 
contralateral body surface, which contains both non-nociresponsive (response to touch) 
and nociresponsive (response to pain or temperature) neurons. Equally, area 1 is highly 
dependent on projections from area 3b for activation, and thus this area also contains a 
second systematic representation of tactile receptors of the contralateral body surface. 
Both area 3a, just rostral to area 3b, and area 2, just caudal to area 1, are activated by 
muscle spindle receptor activity from ventroposterior superior nucleus (VPS), which is 
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concerned with the proprioceptive sensation (Garraghty et al., 1990). However, it has 
been suggested that the architecture (i.e., Brodmann’s areas 3a, 3b, 1 and 2) and functional 
divisions (i.e., pain, touch, temperature and proprioception) in rodents are not clearly 
differentiated and are different from those of primates (Kaas, 2004). 
 
2-1-4. Comparative anatomy of the monkey and rodent frontal cortex 
Moreover, the macaque monkey shares homology with the human in respect to 
anatomical and physiological features of the prefrontal cortex, such as medial prefrontal, 
dorsolateral prefrontal and orbitofrontal areas, which are involved in the emotional 
aspects of pain (Treede et al., 1999; Apkarian et al., 2005). Comparative anatomy of rat, 
monkey and human frontal cortex are reviewed by Wallis (Wallis, 2012). Briefly, 
prefrontal cortex of human and monkey contains three architectonic subdivisions, 
agranular cortex, dysgranular cortex and granular cortex (Wallis, 2012). By contrast, 
several lines of studies have suggested that the rat frontal cortex only has agranular cortex 
(Ongur & Price, 2000; Wallis, 2012). 
 
2-1-5. Hemorrhagic lesion in macaque VPL using collagenase type IV 
In this thesis, hemorrhagic stroke was chosen because this cerebrovascular accident is 
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known to cause CPSP (Leijon et al., 1989; Vestergaard et al., 1995; Greenspan et al., 
2004), and the thalamus is one of the most common region of hemorrhagic stroke in 
humans (Fewel et al., 2003). 
The difference of the brain sizes as well as brain structures between the monkey 
and rodent is thought to be an important factor in development of animal models. In the 
developed rodent models, collagenase type IV, a protease which degrades blood vessels 
and induces hematoma and edema (Rosenberg et al., 1990), was injected at the site of 
VPL with reference to the atlas which coordinates to induce a hemorrhage. Since the 
target site was small, the hemorrhagic lesion sometimes spread beyond the intended site 
(Blasi et al., 2015). The macaque brain is larger than the rodent one, and therefore 
provides advantage of an experimental manipulation; making a focal lesion in VPL, 
which is essential for reproducing symptoms like human patients (Blasi et al., 2015), is 
easier in the macaque than the rodents.  
The VPL is known to have receptive fields on the upper body (Kaas et al., 1984). It 
is reported that pain after a stroke is felt in the body part corresponding to the somatotopic 
representation of the affected brain region (Vestergaard et al., 1995). In the present study, 
to make allodynia and hyperalgesia appear in the monkey’s hand, I intended to induce a 
localized lesion to the receptive field on the hand within the VPL. I firstly confirmed the 
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location of VPL from the structural MRI of each individual brain, and then identified the 
subdivisions that respond to a somatic stimulation of the hand by using 
electrophysiological method (see Materials and Methods of Experiment-1 for detail). 
Thereafter, collagenase type IV was injected to the identified site of the VPL.  
 
2-1-6. Assessment of allodynia and hyperalgesia in macaque monkey 
I focused on the development of allodynia and hyperalgesia after a hemorrhagic lesion in 
macaque VPL because patients with CPSP frequently report the symptoms; non-painful 
mechanical or thermal stimuli (hot or cold) are perceived as painful after the lesion (Klit 
et al., 2009). I considered that the development of allodynia and hyperalgesia can be 
measured objectively by estimating the changes of withdrawal responses to mechanical 
or thermal stimulation, i.e., the decrease of withdrawal threshold to the mechanical 
stimulation (in grams) and thermal stimulation (in sec) after the VPL lesion.  
     Because withdrawal responses of monkeys are the index to evaluate allodynia and 
hyperalgesia, the motor function should not be affected by hemorrhagic lesion. Thus, it is 
thought that the precise identification of location of VPL using electrophysiological 
techniques can prevent damage of the posterior capsule, which carries corticospinal tracts 
passing near the VPL. 
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2-2. Materials and Methods 
2-2-1. Subjects 
Four male adult rhesus macaques (Macaca mulatta) were used in the present study (Table 
1). The macaques were purchased from a local provider (Hamri Co., Ltd., Ibaraki, Japan). 
The animal use protocol was approved by the Institutional Animal Care and Use 
Committee of the National Institute of Advanced Industrial Science and Technology 
(AIST), and were carried out in accordance with guidelines within the “Guide for the Care 
and Use of Laboratory Animals” (Eighth ed., National Research Council of the National 
Academies).  
 
2-2-2. Identification of VPL and collagenase injection 
An artificial stroke was induced unilaterally in the VPL—in the left hemisphere for 
Macaques I and P, and the right for Macaques C and S (Table 1). After a scalp incision 
was made, the skull was exposed, and two MRI-compatible head posts were attached to 
the skull under sterile conditions and pentobarbital anesthesia (25 mg/kg). The location 
of the VPL was determined for each animal, using stereotaxic coordinates from structural 
MRI of each macaque’s brain obtained with a 3.0 T MRI system (Philips Ingenia 3.0 T, 
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Philips Healthcare, Best, the Netherlands). Before the scan, the macaques were 
anesthetized using medetomidine (0.05 mg/kg), midazolam (0.3 mg/kg), and ketamine (4 
mg/kg), and then fixed in a magnet-free stereotaxic frame. The MRI protocols consisted 
of a T1-weighted turbo field echo sequence (repetition time (TR)/echo time (TE), 7.3/3.2 
ms; number of excitations (NEX), 2; flip angle, 8°; field of view, 134 mm × 134 mm; 
matrix, 224 × 224; slice thickness, 0.6 mm; number of slices, 200) and a T2-weighted 
turbo spin echo sequence (TR/TE, 1500/283 ms; NEX, 2; flip angle, 90°; field of view, 
134 mm × 134 mm; matrix, 224 × 224; slice thickness, 0.6 mm).  
Following the MRI, the VPL sub-region involved in tactile sensation of the hand 
digits was identified by electrophysiological recordings. The microelectrode was 
penetrated at 1-mm intervals on the cortical surface, and the somatotopic organization of 
the VPL was determined by recording multiunit activity during light tactile stimuli 
applied to the contralateral body surface with a small hand-held brush. Collagenase type 
IV (C5138; Sigma, St. Louis, MO, USA; 200 U/ml in saline) was then injected in the 
identified VPL sub-region where neurons were activated by tactile stimuli (Fig. 2a-d). A 
single 4-μl injection of collagenase type IV was given to Macaque C, two 4-μl injections 
separated by 1 mm in the dorsoventral direction were given to Macaques P and I, and four 
4-μl injections separated by 1 mm in both dorsoventral and rostrocaudal directions were 
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given to Macaque S (Table 1).  
 
2-2-3. Behavioral procedures 
To evaluate pain perception on the hands after the collagenase injection into the VPL, 
both mechanical and thermal withdrawal tests were performed. During the test, the 
macaque sat in a primate chair made of acrylic glass, and the wrists of both forelimbs 
were fixed to a horizontal plane positioned at the height of the macaque’s waist. An 
opaque board was placed between the face and forelimbs; thus, the macaque did not see 
its own hand while mechanical or thermal stimuli were applied to it. A mechanical 
withdrawal test was conducted by using an electronic von Frey anesthesiometer (IITC 
Life Science, Inc., Woodland Hills, CA, USA) (Fig. 3a). Each von Frey filament was 
applied perpendicularly to the palmar surface of the second, third, and fourth fingers, and 
the maximum pressure exerted (in grams) that triggered hand withdrawal was assessed. 
Two trials were performed for each finger, and the larger pressure was adopted as the 
datum for that day. The withdrawal thresholds for both hands, one contralateral and the 
other ipsilateral to the affected VPL (i.e., the contra-lesional and ipsi-lesional hands), 
were measured 4 days/week during weeks 1 to 4 and 2 days/week during weeks 5 to 12 
after collagenase injection, and then compared to those obtained before lesion induction. 
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On the same day, a thermal withdrawal test was also conducted by using a thermal 
stimulator (SCP-85; As One Corporation, Osaka, Japan) (Fig. 3b). The plate surface was 
maintained at 55–45°C (for heat stimuli), 37°C (for control stimuli) or 10–5°C (for cold 
stimuli), and the macaque’s hand was transferred to the plate. Although the macaque 
freely escaped from hot stimuli, to avoid the risk of low-temperature burn injury from 
prolonged contact with the plate, the duration of a single trial was designed to be no more 
than 1 min. Multiple trials (maximum, five) were performed at each temperature until the 
total contact time with the plate exceeded 90 s. To assess the degree to which the thermal 
stimulus affected withdrawal latencies, the latency for thermal stimulation was divided 
by that for control stimulation at 37°C. This ratio before lesion induction was compared 
to that after lesion induction for both hands. Hand withdrawal latencies were estimated in 
real time during the withdrawal test. In addition, the movements of both hands during the 
test were recorded, by using two digital video cameras (HC-V520M; Panasonic, Osaka, 
Japan) installed around the task apparatus, and a subset of the video data was re-analyzed 
by a person blinded to the treatment of the macaques. The results of this re-analysis were 
consistent with those of the real-time assessments.  
 
2-2-4. Confirmation of lesion site 
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To evaluate the spatiotemporal changes of a stroke, structural MRI scans were performed 
before, and 1 day, 4 days, 1 week, 2 weeks, 1 month, and 3 months after collagenase 
injection. The MRI protocols with both T1- and T2-weighted sequences were the same as 
those described above. The areas that contained edema and hematoma were seen as a 
region of high and low signal intensities, i.e. hyperintense and hypointense areas, in T2-
weighted MRI, respectively (Mack et al., 2003; Kleinschnitz et al., 2005; West et al., 
2009; Zhao et al., 2014). The unbiased volumes for both edema and hematoma were 
calculated by Cavalieri’s principle (Mayhew, 1992), using StereoInvestigator imaging 
software (MBF Bioscience, Williston, VT, USA). In the atlas-based analysis, the T2-
weighted MRIs of macaques that received a collagenase injection into the right 
hemisphere was flipped along the mid-sagittal plane, so that the stroke area was located 
on the left side of the brain. These processed MRIs were matched to macaque brain 
template (voxel size, 0.5 × 0.5 × 0.5 mm) (Black et al., 2004) by using SPM12 software 
(http://www.fil.ion.ucl.ac.uk/spm/). After individual images were processed as described, 
the areas with hypointense signals were delineated manually as regions of interest and 
overlaid onto the template by using MRIcro software (http://www.mricro.com). The size 
and location of the lesion induced by collagenase injection were also evaluated by 
histological analysis. Briefly, the macaques were deeply anesthetized with sodium 
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pentobarbital (35–50 mg/kg, i.v.) and then perfused through the ascending aorta with 0.5 
L of ice-cold saline containing 2 mL (2000 units) of heparin sodium followed by ice-cold 
fixative containing 4% paraformaldehyde and 0.1% glutaraldehyde. The brains were then 
immediately removed and blocked in the coronal plane (5 mm thick). The blocks were 
immersed in a post-fixative solution containing 2% paraformaldehyde and 5% sucrose in 
phosphate buffer for several hours, followed by successive immersions in sucrose 
solutions. They were embedded in optical cutting temperature compound (Miles Inc., 
Elkhart, IN, USA), and rapidly frozen in a dry ice-acetone bath. Brain segments were 
sectioned coronally at a thickness of 18 μm on a cryostat (a Shandon Cryotome SME; 
Thermo Electron Corporation, Pittsburg, PA, USA) and then Nissl-stained with cresyl fast 
violet (Higo et al., 2002; 2004; Higo et al., 2010). Images of the Nissl-stained sections 
were photographed under an Olympus BX60 microscope by using a 3CCD color video 
camera (DV-47d; MBF Bioscience) and then digitized using StereoInvestigator imaging 
software. The lesioned area was defined as the area of a dense concentration of small cells 
(5–10 μm in diameter), which presumably includes both glial cells and blood cells, and 
unbiased volumes were calculated using the same method as that for structural MRI 
analysis.  
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2-2-5. Statistical analysis  
All data are presented as medians and interquartile ranges. Statistical significance was 
assessed by nonparametric tests including a two-tailed Mann–Whitney U-test, Wilcoxon 
signed-rank test, and Kruskal–Wallis one-way analysis of variance (ANOVA) with 
Dunn’s post hoc test. Statistical results were considered significant at P < 0.05. The 
statistical analyses were performed using GraphPad Prism software (GraphPad Software 
Inc., San Diego, CA, USA). 
 
2-3. Results 
2-3-1. Stroke and lesion sizes 
A T2-weighted MRI of a rhesus macaque (Macaque I) 1 day after collagenase injection 
shows that the stroke area, which was seen as a hypointense core and a surrounding 
hyperintense rim, was mainly localized around the thalamus (arrow in Fig. 4a). The areas 
of both hypointense and hyperintense signal intensity expanded from day 1 to day 3 after 
the injection; this may result from expansion of the hematoma and edema (Fig. 4b, c). 
These areas then decreased rapidly over the course of 2 weeks, when the hyperintense 
area almost disappeared. Thereafter, the residual hypointense area was almost stable until 
the end of the experiment 3 months after injection (Fig. 4b). T2-weighted MRIs of the 
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other three macaques (Macaques C, P and S) also indicated a stroke mainly localized 
around the thalamus, and the volume dynamics were similar to that in Macaque I (Fig. 
4d, e). A normalized MRI brain template with atlas-based borders indicated that the stroke 
area at 3 days after collagenase injection, when the stroke was largest, included several 
other thalamic nuclei in addition to VPL (Fig. 4f). By contrast, the stroke area was mainly 
localized within VPL ≥2 weeks after injection. The collagenase-induced lesion was also 
histologically estimated by using Nissl-stained coronal sections (Fig. 5). We defined the 
lesioned area as the area of a dense concentration of small cells (5–10 μm in diameter) 
(Fig. 5a), which presumably include both glial cells and blood cells (Mracsko & Veltkamp, 
2014). The serial coronal sections of Macaque I indicated that the lesion was located 
within the VPL of the thalamus (arrows in Fig. 5c–e). The histological lesion was also 
localized within the VPL of Macaque C. In Macaque S, however, lesions were observed 
not only in the VPL but also in adjacent thalamic nuclei, i.e., the caudal part of the ventral 
lateral nucleus (32% of the total lesion volume) and the reticular nucleus (4%), as well as 
in other brain areas including the caudate nucleus (17 %, Table 1).  
 
2-3-2. Behavioral changes after collagenase injection 
To determine whether a VPL lesion alters pain perception, I evaluated withdrawal 
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responses to both mechanical and thermal stimuli applied to the surface of the hands of 
the macaques before and after collagenase injection. Before the injection, the withdrawal 
responses to both mechanical and thermal stimuli were almost identical for both hands 
(Fig. 6a, b). Moreover, the median withdrawal latencies for thermal stimulation at 50°C 
did not significantly differ from those for control stimulation (37°C) (P = 0.8646, Mann–
Whitney U-test, for the hand contralateral to the hemisphere to be subjected to 
collagenase injection), and the ratios of the withdrawal latency for thermal stimulation to 
that for control stimulation before injection were close to 1 for both hands (Fig. 6b), 
indicating that the macaques consistently responded to each stimulus. During the first 2–
3 days after collagenase injection, all four macaques showed mild paralysis of the hind-
limb contralateral to the injected hemisphere. This may be due to the fact that the posterior 
internal capsule where pyramidal tracts control hind-limb movements was temporarily 
affected by stroke because it is located adjacent to the VPL (Schmahmann & Pandya, 
2006). There was no apparent impairment of movements for other body parts, such as the 
forelimb and face, and the macaques showed no difficulty in grasping a piece of food or 
in eating and drinking. Moreover, the withdrawal responses to both mechanical and 
thermal stimuli during the first week after injection were almost identical to those before 
injection (Fig. 6a, b), indicating that the macaques’ hand movements during the 
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withdrawal tests were not affected by the stroke. The lack of motor paralysis in the 
forelimb indicates that stroke spared the portion of the posterior internal capsule where 
pyramidal tracts control forelimb movements; this site is located several millimeters 
rostral to VPL (Schmahmann & Pandya, 2006).  
A Kruskal–Wallis test revealed significant changes in both the withdrawal 
threshold for mechanical stimulation and the ratio of the withdrawal latency for thermal 
stimulation to that for control stimulations on the hand contralateral to the injected 
hemisphere (i.e., contra-lesional hand) across weeks after the injection (Fig. 6a, b, P < 
0.0001, respectively). Dunn’s post hoc analyses demonstrated a statistically significant 
reduction in both the withdrawal threshold for mechanical stimulation (Fig. 6a, P < 
0.0001) at 8 weeks and the ratio of the withdrawal latency for thermal stimulation to that 
for control stimulation (Fig. 6b, P = 0.0051) at 4 weeks after injection compared with 
those before injection, respectively. The behavioral changes were interpreted as indicating 
the occurrence of both mechanical allodynia and thermal hyperalgesia. The reductions 
lasted until the end of the behavioral experiments, 3 months after the injection. There was 
no correlation between the degree of the reduction and the dosage of collagenase, e.g., 
the ratios of the withdrawal threshold at 12 weeks after the injection to that before 
injection were 0.68, 0.27, 0.51, and 0.55 in Macaques C (4μl), I (8μl), P (8μl), and S 
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(16μl), respectively. I did not observe significant change for mechanical withdrawal 
responses on the hand ipsilateral to the injected hemisphere, i.e., the ipsi-lesional hand 
(Fig. 6a). Although the median ratio of the withdrawal latency on the ipsi-lesional hand 
for thermal stimulation at 50°C to that for control stimulation showed a tendency to 
decrease, the decrease was not statistically significant (Fig. 6b). Even though no motor 
paralysis was detected after collagenase injection, all four macaques rarely used the 
contra-lesional hand to retrieve food in their cages; this behavior suggests that mechanical 
allodynia developed in the contra-lesional hand. I also evaluated changes in withdrawal 
latency for thermal stimulation at temperatures other than 50°C (Fig. 6c). No significant 
change was observed for withdrawal latency on either the contra- or ipsi-lesional hands 
for thermal stimulation at 45°C or cold stimuli (10–5°C) at 3 months after the injection. 
The withdrawal latency for thermal stimulation at 55°C compared with that for control 
stimulation before injection was less than 1 for both hands, indicating that the intact 
monkeys sensed thermal stimulation at 55°C as a nociceptive stimulus. I measured 
withdrawal latency to thermal stimulation at 55°C to confirm that the macaques remained 
able to withdraw in response to nociceptive stimuli after collagenase injection. The 
withdrawal latency to stimulation at 55°C did not increase after collagenase injection, 
suggesting a lack of motor impairment. Rather, it significantly decreased for both hands 
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at 3 months after the injection compared with the value before injection (P < 0.0001, 
Mann–Whitney U-test), although the latency on the ipsi-lesional hand was longer than 
that on the contra-lesional hand at 3 months after injection (P = 0.0464, Wilcoxon signed-
rank test). These results suggest that mild hypersensitivity to heat stimuli occurred in the 
ipsi-lesional hand. 
 
2-4. Discussion 
In Experiment-1, I developed a primate model of CPSP based on a hemorrhagic focal 
lesion induced in the VPL of rhesus macaques. The lesioned macaques showed behavioral 
changes that were interpreted as the development of both allodynia to mechanical 
stimulation and hyperalgesia to hot thermal stimulation.  
In rodent models of CPSP, the onsets of mechanical allodynia and thermal 
hyperalgesia occur within 1 week after hemorrhage induction by injecting collagenase 
around the VPL (Wasserman & Koeberle, 2009; Castel et al., 2013; Hanada et al., 2014). 
However, a majority of patients with CPSP begin to complain of the abnormal pain a 
delay of several weeks after a stroke (Kumar et al., 2009). A similar delay in the onset of 
CPSP was recently reported in rats based on focal ischemic lesion in thalamus by injection 
of endothelin-1 (Blasi et al., 2015). Unfortunately, this model exhibited thermal 
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hyperalgesia but not mechanical allodynia, which is one of the most common symptoms 
of patients with CPSP (Bowsher, 2005; Klit et al., 2009). Thus, the present model using 
macaques, in which significant behavioral changes to both mechanical and thermal 
stimuli were observed after 4 weeks when edema and hematoma was stabilized from the 
induction of hemorrhage, more faithfully reproduced the symptoms of CPSP patients than 
the other experimental animal models. The difference between the present and previous 
models may reflect a species difference or differences in the size and location of the lesion. 
In recent models using rodents, the injection sites for collagenase type IV and endothelin-
1 were determined using stereotaxic coordinates. In the experiment, in contrast, the 
injection site was determined not only by structural MRI of an individual macaque but 
also by the result from electrophysiological recordings in which the location of the VPL 
sub-region responsive to tactile stimulation of the hand digits was identified. These 
techniques, in combination with the relatively large brain of rhesus macaques, contributed 
to inducing a hemorrhagic lesion within the VPL more focal than those induced in 
previous rodent models.  
     Although I observed behavioral changes in the contra-lesional hand that were 
interpreted as reflecting development of both mechanical allodynia and thermal 
hyperalgesia, behavioral changes interpreted as the development of mild thermal 
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hyperalgesia were also ascertained in the ipsi-lesional hands. Kim (1998) reported that 
some human patients with severe CPSP have milder sensory symptoms on the side 
ipsilateral to the lesion than the side contralateral to the lesion. It has been reported that 
there are certain indirect sensory pathways, the spino-reticulo-thalamic pathways 
involved in distributing pain and arousal terminate in bilaterally medial thalamus 
(Carstens et al., 1990; Kim, 1998; Villanueva et al., 1998). Moreover, a recent study 
reported bilateral cortical atrophy in patients with CPSP (Krause et al., 2016). The 
physiological and pathophysiological anatomical findings suggest that unilateral 
thalamus lesion may contribute to the bilateral sensation of abnormal pain. The present 
macaque model will aid in understanding plastic changes in neuronal structures involved 
in the bilateral symptom. 
     The present macaque models did not display behavioral changes reflective of 
hyperalgesia to cold stimulation which are also common in the patients with CPSP. 
However, I do not consider that the lack of cold hyperalgesia in the present macaque 
model indicates a critical difference from symptoms of human patients because reduction 
or less of cold sensation was reported in human patients in case the lesion is confined to 
the ventral posterior area in the thalamus (Kim et al., 2007).  
Note that the stroke area at 3 days after injection of collagenase, when the stroke 
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area was largest, included several other thalamic nuclei, such as the pulvinar and MD 
nuclei. Therefore, plastic changes resulted from damage to thalamic nuclei other than the 
VPL may continue even after the stroke has stabilized and might participate to induce 
CPSP. The present study is the first to use MRI to demonstrate the spatiotemporal changes 
of a thalamic stroke and suggests that lesions based on histological confirmation after the 
completion of behavioral tests may be substantially underestimated because stroke lesion 
size transiently increased and finally decreased after stroke. 
In the case of using this new macaque model, a next important step may be to 
investigate how the size and location of the lesion affect the symptoms of CPSP. 
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2-5. Figures and figure legends 
 
 
 
 
 
 
 
 
Figure 2. Electrophysiological identification of hand area in VPL. (a-d) Coordinate 
representation of sensory response and the site of collagenase injection (cross). The 
symbols (circle, quadrate and triangle) indicate representative somatotopic organization 
derived using multiunit activity recording during tactile stimulation applied to the 
contralateral body parts. The white rectangle and dotted line on the axial MR image 
including VPL (depth is 5 mm from the cortical surface) of each macaque indicate the 
recording area and interaural line, respectively. The depth profiles of all symbols from 
cortical surface (in mm) were represented as a color related to scale bar (e). A, Anterior; 
L, Lateral. 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Assessment of withdrawal response. During behavioral tests, the monkey sat 
in the primate chair and experience the mechanical withdrawal test using von Frey 
filaments (a) and thermal withdrawal test using thermal stimulator (b). Yellow arrow in 
(a) shows contact point between the von Frey filament and dorsal surface of the digit.  
 
  
a 
b 
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Figure 4. Time course of stroke after injection. (a) Coronal T2-weighted MRIs of 
Macaque I showing time course of stroke after the injection. The area that contained a 
hematoma and edema was seen as the hypointense stroke core (arrows) and the 
surrounding hyperintense rim. The coronal images were obtained through the rostro-
caudal level at which the VPL is located. (b, c) Temporal changes of the hypointense (b) 
and hyperintense areas (c) in successive coronal images of Macaque I are shown as a 
function of rostral distance from the interaural line. In this macaque, 4 to 17 mm rostral 
to the interaural line corresponds to the level at which the thalamus is located. (d, e) 
Temporal volume changes of the hypointense (d) and hyperintense areas (e) are shown 
for all four collagenase-injected rhesus macaques. In all animals, the areas of both 
hypointense and hyperintense signal intensity decreased at 2 weeks after the collagenase 
injection, when the hyperintense area almost disappeared. Thereafter, the residual 
hypointense area was almost stable until 12 weeks after injection. (f) Using a normalized 
MRI brain template and atlas-based borders, it was indicated that the stroke area at 3 days 
after collagenase injection included the VPL and several additional thalamic nuclei. 
However, at 2 weeks and 12 weeks after injection and thereafter, the lesion was mainly 
localized within VPL. The colors indicate the number of macaques with hypointense 
signals in the indicated voxels. Cd, caudate nucleus; CM, central medial nucleus; GLd, 
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dorsal lateral geniculate nucleus; LD, lateral dorsal nucleus; LP, lateral posterior nucleus; 
MD, mediodorsal nucleus; Pul, pulvinar nucleus; R, reticular nucleus; SG, 
suprageniculate nucleus; VLo, oral part of the ventrolateral nucleus; VLc, caudal part of 
the ventrolateral nucleus; VLps, ventrolateral nucleus, pars postrema; VPM, ventral 
posteromedial nucleus; VPI, ventral posteroinferior nucleus; VPL, ventral posterolateral 
nucleus. 
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Figure 5. Confirmation of lesional area. (a) A Nissl-stained coronal section showing 
both the lesional and perilesional areas in the VPL. The lesional area was defined by a 
dense concentration of small cells (5–10 μm in diameter), which presumably includes 
both glial cells and blood cells. The boundary between the lesional and perilesional areas 
is indicated by the white dotted line (left, lesional area; right, perilesional area). Large 
cells (20–40 μm in diameter, arrowheads) presumed to be neurons were observed in the 
perilesional area. Scale bar: 50 μm. (b-f) Serial Nissl-stained coronal sections of Macaque 
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I, spaced by approximately 600 μm, are arranged from rostral (b) to caudal (f). Note that 
the lesion was located within the VPL. Scale bar: mm. CM, central medial nucleus; LP, 
lateral posterior nucleus; MD, mediodorsal nucleus; Pul, pulvinar nucleus; SG, 
suprageniculate nucleus; VLc, caudal part of the ventrolateral nucleus; VPM, ventral 
posteromedial nucleus; VPL, ventral posterolateral nucleus; VPI, ventral posteroinferior 
nucleus. 
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Figure 6. Behavioral changes after collagenase injection. (a, b) Weekly changes in the 
withdrawal response to mechanical and thermal stimulation. The withdrawal thresholds, 
shown as the pressure exerted (in grams, a), and the latencies, represented as the ratio of 
the withdrawal latency for thermal stimulation (50°C) to that for control stimulation 
(37°C, b), are shown for both hands, one contralateral (contra-lesional hand) and the other 
ipsilateral (ipsi-lesional hand) to the injected hemisphere. Medians and interquartile 
ranges for the four collagenase-injected macaques are shown. Several weeks following 
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the injection, both the withdrawal threshold for mechanical stimulation and withdrawal 
latency for thermal stimulation on the contralateral hand significantly decreased relative 
to those before the injection, but not observed on the ipsilateral hand. The reductions 
lasted until the end of the behavioral experiment 3 months after the injection. **P < 0.01 
and ****P < 0.0001, compared with pre-injection (Kruskal–Wallis one-way ANOVA 
followed by Dunn’s post hoc test). ✝P < 0.05, ✝✝P < 0.01, and ✝✝✝✝P < 0.0001, compared 
with ipsi-lesional hand (Wilcoxon signed-rank test). (c) Medians and interquartile ranges 
for the withdrawal latency for thermal stimulations other than 50°C before and at 12 
weeks after injection. The withdrawal latencies for 55°C on the both contra- and ipsi-
lesional hands significantly decreased relative to those before injection (****P < 0.0001, 
Mann-Whitney U test), although the latency on the ipsi-lesional hand was longer than that 
on the contra-lesional hand at 12 weeks after injection (✝P < 0.05, Wilcoxon signed-rank 
test). 
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2-6. Table 
Table 1. Collagenase-injected rhesus macaques used in the present study 
 
Weight, 
kg 
Injected 
hemisphere 
Dosage of 
collagenase, 
μl 
Lesion 
volume, 
mm3 
Post-injection 
survival 
period, days 
Macaque C 
Macaque I 
Macaque P 
Macaque S 
8.5 
8.0 
8.9 
8.6 
Right 
Left 
Left 
Right 
4 
8 
8 
16 
2.1 
3.9  
-* 
7.3 (1.5) ** 
104 
92 
- 
113 
*Data not available because the macaque is not killed for this study. 
**The lesion volume outside the thalamus is shown in parentheses. 
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Chapter 3. [Experiment 2] Evaluation of activated glial cells 
around lesion area 
 
3-1. Introduction 
3-1-1. Glial activation and neuropathic pain 
Glial cells have recently attracted attention for their role in plasticity (Eroglu & Barres, 
2010). Specifically, researchers in the field of neuropathic pain have been devoting 
considerable attention to glial cells because they are involved in pain symptoms and are 
therefore key to developing pain-relieving drugs. The relationship between glial cells and 
neuropathic pain after spinal cord and peripheral nerve injuries has been well studied in 
animals. In the first part of this section, I will briefly describe why glial cells are 
considered to be associated with abnormal pain. 
Glial cells are classified into microglia, astrocytes, and oligodendrocytes. Microglia, 
which are the resident immune cells of the central nervous system, are dormant under 
normal conditions, but are immediately activated in response to several conditions, 
including systemic inflammation and brain injury (Ladeby et al., 2005; Raivich, 2005). A 
previous report suggested that activated microglia in the dorsal horn may underlie the 
abnormal pain experienced following peripheral nerve and spinal cord injuries (Tsuda et 
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al., 2003). A well-known mechanism by which activated microglia induce pain is a 
“depolarizing shift of EGABA” (γ-aminobutyric acid (GABA)-induced chloride ion 
response) (Tsuda, 2016), which is thought to result according to the following: (1) 
Activation of microglial P2X4 receptors (subtypes of an ionotropic receptor P2X, of which 
there are seven types: P2X1–P2X7) stimulates the synthesis and release of brain-derived 
neurotrophic factor (BDNF) (Ulmann et al., 2008). (2) Thereafter, BDNF alters several 
molecular pathways of spinal lamina I neurons and downregulates the neuronal chloride 
ion transporter (K-Cl cotransporter; KCC2) (Morgado et al., 2011), which extrudes 
chloride ions from the cell (Hubner et al., 2001). (3) As a consequence, GABA elicits 
excitatory depolarization, rather than inhibitory hyperpolarization, in the dorsal horn 
neurons with a decrease in KCC2 expression. Thus, when activated by nociceptive 
stimulation, the lamina I neurons produce aberrant nociceptive output to the thalamus and 
contribute to allodynia or hyperalgesia after nerve injury (Tsuda, 2016). 
       Astrocytes are also activated following nerve injury (Miyoshi et al., 2008; Doyen 
et al., 2017), and the activated astrocytes in the dorsal horn also contribute to abnormal 
pain. Miyoshi et al. (2008) found that interleukin (IL)-18 and IL-18 receptors were 
upregulated in activated astrocytes in the spinal dorsal horn after nerve injury, and 
functional inhibition of IL-18 signaling pathways attenuated the tactile allodynia.   
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3-1-2. Activated glial cells and CPSP 
It has been recently reported that glial cells are also associated with allodynia or 
hyperalgesia following VPL lesion. Hanada et al. (2017) reported activated microglia in 
the vicinity of lesioned VPLs and reported that pain-like behaviors in a mouse model 
decreased following the infusion of minocycline, which is known to attenuate microglial 
activation (Bastos et al., 2012). Additionally, successful reduction of pain was achieved 
by infusion of an antagonist of the P2X7 receptor (Kuan et al., 2015), which is important 
for activating microglia in brain tissues (Monif et al., 2010). These results led to the 
hypothesis that the interaction between the microglia and neurons in the VPL is also 
involved in the onset of CPSP. Hence, as the first step, I investigated histological changes 
in microglia and astrocytes and examined neuronal degeneration in the perilesional area 
using a macaque CPSP model. 
 
3-2. Materials and methods 
3-2-1. Subjects 
Three male adult rhesus macaques (Macaca mulatta) were used in this study (Macaques 
C, I, and S; Table 1). I also used the brain tissues of three intact macaques weighing 5.1, 
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7.5, and 8.0 kg as the controls for the immunohistochemical analysis (see below). The 
macaques were purchased from a local supplier (Hamri Co., Ltd., Ibaraki, Japan). The 
animal use protocol was approved by the Institutional Animal Care and Use Committee 
of AIST, and the experiment was carried out in accordance with the Guide for the Care 
and Use of Laboratory Animals (Eighth edition; National Research Council of the 
National Academies).  
  
3-2-2. Immunohistochemistry 
The macaque tissues used for this experiment were prepared in the same manner as in 
Experiment 1. 
To characterize the degree of microglial and astrocyte reactivity, and the extent of 
neuronal degeneration, I performed immunohistochemistry 3 months after the 
collagenase injection to detect the presence of ionized calcium-binding adaptor molecule 
1 (Iba-1), glial fibrillary acidic protein (GFAP), and neuronal nuclear antigen (NeuN) on 
the brain sections obtained from Macaques C, I, and S. The immunohistochemistry 
analysis for each antigen was performed with a rabbit anti-Iba-1 polyclonal antibody 
(1:16,000, cat. no. 019-19741; Wako Pure Chemicals, Osaka, Japan), a rabbit anti-GFAP 
polyclonal antibody (1:125, cat. no. Z0334; Dako, Glostrup, Denmark), and a mouse anti-
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NeuN monoclonal antibody (1:50, cat. no. MAB377; Chemicon, Temecula, CA, USA), 
respectively. The immunocomplex was visualized by the avidin-biotin-peroxidase 
method. The Vectastatin® Elite ABC Rabbit IgG Kit (PK-6101; Vector Laboratories, Inc., 
Burlingame, CA, USA) was used for Iba-1 and GFAP staining and the Vectastatin® Elite 
ABC Mouse IgG Kit (PK-6102; Vector Laboratories, Inc.) was used for NeuN staining. 
The color reaction was developed using diaminobenzidine for the substrate (Dojindo 
Laboratories, Kumamoto, Japan) according to the manufacturer’s instructions. To 
investigate whether microglia and astrocytes were located in the vicinity of neurons in 
the perilesional VPL, double-labeling immunofluorescence was also performed. In the 
double-labeling experiments, either the anti-Iba-1 or the anti-GFAP antibody was 
incubated with the anti-NeuN antibody; it was then visualized using Alexa 488-
conjugated goat anti-rabbit IgG and Alexa 546-conjugated goat anti-mouse IgG 
(Invitrogen, Waltham, MA, USA). Sections were washed and then covered with 
Fluoromount/Plus™ (Diagnostic Biosystems, Pleasanton, CA, USA).  
To quantify the immunoreactivity in the perilesional area, the relative optical 
density (OD) for each antigen was measured in a 100-µm × 100-µm square that was 
randomly drawn around the border of the lesion using Image J software (National 
Institutes of Health, Bethesda, MD, USA). The OD was also measured in 200-µm × 200-
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µm squares sampled at distances 100–300, 300–500, 500–700, 700–900, 900–1,100, and 
1,100–1,300 µm from the border. For each antigen, 10 squares were measured for each 
distance, and the OD of the background staining was also measured in 10 200-µm × 200-
µm squares that represented the neighboring white matter in each section. I evaluated the 
staining intensity by calculating the percentage of OD above the background level of each 
square in the perilesional VPL. Then, the OD value in the perilesional VPL was 
normalized to the average of the values obtained from the VPL of the contra-lesional 
hemisphere and the corresponding VPL of normal intact macaques. 
 
3-2-3. Statistical analysis 
All immunohistochemical data are presented as medians and interquartile ranges. 
Statistical significance was assessed by nonparametric tests, including a two-tailed 
Mann–Whitney U test and a Kruskal–Wallis one-way analysis of variance (ANOVA) with 
Dunn’s post hoc test. Statistical significance was set at P < 0.05, and the analyses were 
performed using GraphPad Prism software (GraphPad Software Inc., San Diego, CA, 
USA). 
 
3-3. Results 
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To characterize the degree of microglial and astrocyte reactivity, as well as the extent of 
neuronal degeneration, I performed immunohistochemistry 3 months after collagenase 
injection to detect Iba-1, GFAP, and NeuN on brain sections obtained from Macaques C, 
I, and S. Furthermore, I observed cells with shapes characteristic of activated microglia, 
i.e., enlarged cells with thickened proximal processes and reduced ramification of distal 
branches (arrows in Fig. 7a) (Ladeby et al., 2005; Raivich, 2005). Iba-1-positive cells 
were abundant not only in the lesional area, defined by a dense concentration of small 
cells (5–10 μm in diameter) in the Nissl-stained section, but also in the perilesional area, 
several hundred μm from the border of the lesional area (Fig. 7e). GFAP-positive cells 
were also abundant in the perilesional area at 3 months after collagenase injection (Fig. 
7c, f). Additionally, I observed cells with shapes characteristic of activated astrocytes, i.e., 
enlarged cell bodies and thick processes (arrows in Fig. 7c) (Sofroniew, 2009). No 
activated microglia or astrocytes were detected in the VPL of the hemisphere contralateral 
to the collagenase injection (Fig. 7b, d), and the OD values of the Iba-1 and GFAP of the 
VPL of the contra-lesional hemisphere did not significantly differ from those of normal 
intact macaques (Iba-1, P = 0.5718, GFAP, P = 0.7412, Mann–Whitney U test). I also 
performed immunohistochemistry for NeuN and confirmed the presence of neurons in 
the perilesional area, although the neurons close to the lesional area were less dense than 
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those in the intact VPL (Fig. 7g). Double-labeling immunofluorescence indicated that 
both Iba-1-positive microglia and GFAP-positive astrocytes existed in the vicinity of 
surviving neurons in the perilesional area, and the neurons were surrounded by the 
processes of the activated microglia and astrocytes (Fig. 8a, b).  
 
3-4. Discussion  
As described in the Introduction section in this chapter, previous studies using rodent 
models have shown that microglial activation is associated with the pathophysiology of 
CPSP (Wasserman & Koeberle, 2009; Hanada et al., 2014; Kuan et al., 2015), and that 
pain-like behaviors are reduced by infusions of minocycline and P2X7 receptor 
antagonists (Hanada et al., 2014; Kuan et al., 2015), which are known to attenuate 
microglial activation (Monif et al., 2010; Bastos et al., 2012). The present experiments 
also showed microglial activation both the perilesional and lesional areas. In contrast to 
the rodent CPSP models described above (Wasserman & Koeberle, 2009; Hanada et al., 
2014), in which significantly increased immunoreactivity in the perilesional area for Iba-
1 was confirmed until 1 month post-injection, the present results showed a significant 
increase even at 3 months post-collagenase injection. Taken together with the results of a 
immunohistological study of rhesus macaques with a motor cortex lesion, which 
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demonstrated that microglial activation persists for 12 months after the lesion (Nagamoto-
Combs et al., 2007), the present results suggest that the temporal dynamics of microglial 
activation differ between primates and rodents. Thus, the macaque model of CPSP may 
have an advantage over the other experimental models for testing therapeutic 
interventions that last for several months, such as rehabilitative training and continuous 
pharmacological treatment. 
Although there is no direct evidence to prove that abnormal excitation of neurons 
attributable to microglial activation occurs in CPSP patients, a previous study reported an 
unusual pattern of neural activity, i.e., a burst discharge, in the perilesional area of patients 
with CPSP of thalamic origin (Hirato et al., 2010). In a rodent model of CPSP, increased 
neural activity of the MD and the cingulate cortex were attenuated by suppressing 
microglial activation of the thalamus (Kuan et al., 2015). This evidence indicates that 
plastic changes of neurons may occur not only in the perilesional area, but also in areas 
distant from the lesioned site.  
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3-5. Figures and figure legends 
 
 
  
53 
 
Figure 7. Glial activation in the perilesional area at 3 months after collagenase 
injection. (a-d) Coronal sections showing localization of the ionized calcium-binding 
adaptor molecule 1 (Iba-1) and glial fibrillary acidic protein (GFAP) in the VPL of both 
the collagenase-injected (a, c) and contralateral hemispheres (b, d). (a) Iba-1-positive 
cells were shown to have the characteristic shapes of activated microglia (i.e., enlarged 
cells with thickening of proximal processes and reduced ramification of distal branches 
(arrows)) in the perilesional area (the left side of the dotted line). (b) No activated 
microglia were detected in the VPL of the contralateral hemisphere. (c, d) GFAP-positive 
cells with characteristic shapes of activated astrocytes (i.e., enlarged cells with thickening 
of proximal processes) were observed in the perilesional area (arrows in c) but not in the 
contralateral hemisphere (d). Scale bar: 100 μm. (e–g) Immunoreactivities of Iba-1 (e), 
GFAP (f), and neuronal nuclear antigen (NeuN) immunoreactivity (g) in the perilesional 
area are shown as a function of distance from the border of the lesional area. The optical 
density (OD) of immunoreactivity was normalized to the values obtained from the VPL 
of the contra-lesional hemisphere and those in the corresponding VPL of normal intact 
macaques. *P < 0.05, **P < 0.01, and ***P < 0.001 (Kruskal–Wallis one-way ANOVA 
followed by Dunn’s post hoc test). 
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Figure 8. Surviving neurons in the perilesional area of the VPL were surrounded by 
processes of activated microglia and astrocytes. (a, b) Representative 
immunofluorescence images showing localizations of neurons (NeuN; magenta), 
microglia (Iba1; green in a), and astrocytes (GFAP; green in b) at < 200 μm from the 
border of the lesional area. Scale bar: 100 μm. 
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BDNF: brain-derived neurotrophic factor 
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CPSP: central post-stroke pain 
fMRI: functional magnetic resonance imaging  
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GFAP: glial fibrillary acidic protein 
GLd: dorsal lateral geniculate nucleus  
Iba-1: ionized calcium binding adaptor molecule 1 
IC: insular cortex 
IL: interleukin 
KCC2: K-Cl cotransporter 
MD: mediodorsal nucleus 
MI: primary motor cortex 
MRI: magnetic resonance imaging  
NeuN: neuronal nuclear antigen  
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LP: lateral posterior nucleus 
OD: optical density 
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PFC: prefrontal cortex 
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R: reticular nucleus 
SG: suprageniculate nucleus 
SI: primary somatosensory cortex 
SII: secondary somatosensory cortex 
TE: echo time 
TR: repetition time 
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VBM: voxel-based morphometry  
VMpo: ventral medial posterior nucleus 
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VLps: ventrolateral nucleus, pars postrema 
VPL: ventral posterolateral nucleus 
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Conclusion 
 
Central post-stroke pain (CPSP) can occur as a result of cerebrovascular accidents in the 
ventral posterolateral nucleus (VPL) of the thalamus. Here, a macaque model of CPSP 
based on a focal hemorrhagic lesion in the VPL was developed. Several weeks after 
induction of hemorrhage, the macaques showed behavioral changes that were interpreted 
as reflecting the occurrence of both mechanical allodynia and thermal hyperalgesia. 
Moreover, the macaques showed brain activity changes consistent with pain-related 
activity in human patients and long-lasting microglial activation that may be 
characteristic of primate brains. The present macaque model, which reproduces the 
symptoms of CPSP patients, will contribute not only to understanding the neurological 
changes underlying CPSP but also to the development of novel therapeutic interventions. 
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